Events
-
June 6, 2018 - June 7, 2018
Third Annual CPP Member Meeting 2018
The third annual CPP Member Meeting (June 6-7, 2018 in London, UK) provided a face-to-face forum for industry, regulators, academic experts and advocacy organizations to collaborate towards the development of Parkinson’s disease therapies. This meeting provided a unique opportunity for stakeholders to celebrate the successes of the consortium to date and align on future options... -
May 10, 2018
Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018)
This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of ePRO technology in clinical trials. The goal of the webinar is to promote consistent and sufficient training prior to initiating data collection. Presenters: Jenny J. Ly, PhD (ERT) and Serge Bodart, MSc (Bracket) PDF version -
April 25, 2018 - April 26, 2018
Ninth Annual Patient-Reported Outcome Consortium Workshop
April 25 – 26, 2018 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 25-26, 2018 the NINTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP was held in Silver Spring, Maryland. The overall Workshop objectives were to: Provide an update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and address changes associated with... -
April 11, 2018 - April 12, 2018
2018 Annual International Neonatal Scientific Workshop
Bethesda North Marriott Hotel & Conference Center, Maryland Agenda – Day 1, April 11, 2018 8:00 am – 12:00 pm INC Hemodynamic Adaptation Workgroup Meeting Heike Rabe and Janis Dionne, co-chairs 8:00 am – 12:00 pm INC BPD Workgroup Meeting Robin Steinhorn and Wolfgang Göpel, co-chairs 12:00 pm – 1:00 pm Lunch 1:00 pm... -
November 6, 2017 - November 7, 2017
Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017
On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and...